Entity
  • Leads To Development

    Created in 2009
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,071
  • Activities

  • Technologies

  • Entity types

  • Location

    202 Rue de la Croix Nivert, 75015 Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 19

  • SIREN

    513398164
  • Engaged corporates

    5
    0 1
  • Added in Motherbase

    3 years, 8 months ago
Description
  • Value proposition

    Your expert drug development partner, guiding your asset to and through the clinic

    If you’ve only got one shot at getting your drug to the clinic, we’ll help you make it the best one.

    At Leads to Development, we enable biotech companies to bring novel drugs to and through clinical trials as efficiently and smoothly as possible.

    With decades of experience and more than 160 projects under our belt throughout Europe and the US, our team provides comprehensive end-to-end support across all areas of new drug development.

    Our backgrounds are in biotech rather than big pharma, so we understand the unique challenges you face on the journey to the clinic. We’re with you every step of the way, from early drug discovery through to market authorisation.

    We provide:

    • Bespoke development plans designed to meet your goals
    • Regulatory strategies that hit the mark first time - we have a 100% success rate in obtaining clinical trial authorisation, including innovative and ground-breaking products
    • Toxicology, pharmacology, production and manufacturing know-how that saves you time and money
    • Expert support for scientific advice, pre-IND, CTA, IND, and more
    • Clinical oversight to ensure efficient and compliant trial initiation and execution
    • Proactive project management from a dedicated team committed to your success

    Thanks to our support, many of our clients have achieved successful out-licensing deals or company buyouts, including a recent deal valued at nearly $3 Bn.

    “You are doing a great job! It is really nice to work with the whole L2D team, everything is always delivered on time and very professionally done"
    - Cécile Bougeret, Vice President Operations at EVEXTA BIO

    Get in touch to discuss your project today: contacts@leadstodevelopment.com

    Consultancy, Operational project management, Preclinical development, Biotechnology, Drug development, Biopharma, Regulatory strategy, Clinical oversight, Non-clinical development, Toxicology expertise, Quality assurance, Production & manufacturing, Pharmacology expertise, and Development planning

  • Original language

    Your expert drug development partner, guiding your asset to and through the clinic

    If you’ve only got one shot at getting your drug to the clinic, we’ll help you make it the best one.

    At Leads to Development, we enable biotech companies to bring novel drugs to and through clinical trials as efficiently and smoothly as possible.

    With decades of experience and more than 160 projects under our belt throughout Europe and the US, our team provides comprehensive end-to-end support across all areas of new drug development.

    Our backgrounds are in biotech rather than big pharma, so we understand the unique challenges you face on the journey to the clinic. We’re with you every step of the way, from early drug discovery through to market authorisation.

    We provide:

    • Bespoke development plans designed to meet your goals
    • Regulatory strategies that hit the mark first time - we have a 100% success rate in obtaining clinical trial authorisation, including innovative and ground-breaking products
    • Toxicology, pharmacology, production and manufacturing know-how that saves you time and money
    • Expert support for scientific advice, pre-IND, CTA, IND, and more
    • Clinical oversight to ensure efficient and compliant trial initiation and execution
    • Proactive project management from a dedicated team committed to your success

    Thanks to our support, many of our clients have achieved successful out-licensing deals or company buyouts, including a recent deal valued at nearly $3 Bn.

    “You are doing a great job! It is really nice to work with the whole L2D team, everything is always delivered on time and very professionally done"
    - Cécile Bougeret, Vice President Operations at EVEXTA BIO

    Get in touch to discuss your project today: contacts@leadstodevelopment.com

  • Nonclinical, CMC & Regulatory Drug Development Consulting Services

    Nonclinical, CMC & Regulatory Drug Development Consulting Services. Accelerating your new drug development. Ready-to-go committed team for rapid delivery. 150+ programmes delivered.

  • https://leadstodevelopment.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Takeda
Takeda
Pharmaceutical, Pharmaceutical Manufacturing
Takeda
Pharmaceutical, Pharmaceutical Manufacturing
Other

26 Sep 2024


Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

26 Sep 2024


Gustave Roussy
Gustave Roussy
Health, Hospitals and Health Care
Gustave Roussy
Health, Hospitals and Health Care
Other

26 Sep 2024


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

26 Sep 2024


Institut Curie
Institut Curie
Health, Hospitals and Health Care
Institut Curie
Health, Hospitals and Health Care
Other

26 Sep 2024


Similar entities
Loading...
Loading...
Social network dynamics